Bottero M - Search Results

1

Stereotactic Ablative Radiation Therapy in 3 Fractions Induces a Favorable Systemic Immune Cell Profiling in Prostate Cancer Patients.

Palermo B, Bottero M, Panetta M, Faiella A, Sperduti I, Masi S, Frisullo G, Foddai ML, Cordone I, Nisticò P, Sanguineti G. Palermo B, et al. Among authors: bottero m. Oncoimmunology. 2023 Feb 13;12(1):2174721. doi: 10.1080/2162402X.2023.2174721. eCollection 2023. Oncoimmunology. 2023. PMID: 36798427 Free PMC article.

2

Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis.

Piacente F, Bottero M, Benzi A, Vigo T, Uccelli A, Bruzzone S, Ferrara G. Piacente F, et al. Among authors: bottero m. Int J Mol Sci. 2022 Apr 14;23(8):4352. doi: 10.3390/ijms23084352. Int J Mol Sci. 2022. PMID: 35457169 Free PMC article. Review.

3

Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review.

Achard V, Bottero M, Rouzaud M, Lancia A, Scorsetti M, Filippi AR, Franzese C, Jereczek-Fossa BA, Ingrosso G, Ost P, Zilli T. Achard V, et al. Among authors: bottero m. Acta Oncol. 2020 Oct;59(10):1224-1234. doi: 10.1080/0284186X.2020.1775291. Epub 2020 Jun 13. Acta Oncol. 2020. PMID: 32536241

4

A Prospective Study Assessing the Post-Prostatectomy Detection Rate of a Presumed Local Failure at mpMR with Either ⁶⁴CuCl₂ or ⁶⁴CuPSMA PET/CT.

Faiella A, Sciuto R, Giannarelli D, Bottero M, Farneti A, Bertini L, Rea S, Landoni V, Vici P, Ferriero MC, Sanguineti G. Faiella A, et al. Among authors: bottero m. Cancers (Basel). 2021 Nov 6;13(21):5564. doi: 10.3390/cancers13215564. Cancers (Basel). 2021. PMID: 34771726 Free PMC article.

5

A prospective study assessing the pattern of response of local disease at DCE-MRI after salvage radiotherapy for prostate cancer.

Bottero M, Faiella A, Giannarelli D, Farneti A, D'Urso P, Bertini L, Landoni V, Vici P, Sanguineti G. Bottero M, et al. Clin Transl Radiat Oncol. 2022 Apr 27;35:21-26. doi: 10.1016/j.ctro.2022.04.010. eCollection 2022 Jul. Clin Transl Radiat Oncol. 2022. PMID: 35516461 Free PMC article.

6

A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective.

Ingrosso G, Bottero M, Becherini C, Caini S, Alì E, Lancia A, Ost P, Sanguineti G, Siva S, Zilli T, Francolini G, Bellavita R, Aristei C, Livi L, Detti B. Ingrosso G, et al. Among authors: bottero m. Semin Oncol. 2022 Oct;49(5):409-418. doi: 10.1053/j.seminoncol.2022.09.005. Epub 2022 Sep 24. Semin Oncol. 2022. PMID: 36192243 Review.

7

A Systematic Review on the Impact of Hypofractionated and Stereotactic Radiotherapy on Immune Cell Subpopulations in Cancer Patients.

Takanen S, Bottero M, Nisticò P, Sanguineti G. Takanen S, et al. Among authors: bottero m. Cancers (Basel). 2022 Oct 22;14(21):5190. doi: 10.3390/cancers14215190. Cancers (Basel). 2022. PMID: 36358608 Free PMC article. Review.

8

The Prognostic Value of DCE-MRI Findings before Salvage Radiotherapy after Radical Prostatectomy.

Farneti A, Bottero M, Faiella A, Giannarelli D, Bertini L, Landoni V, Vici P, D'Urso P, Sanguineti G. Farneti A, et al. Among authors: bottero m. Cancers (Basel). 2023 Feb 15;15(4):1246. doi: 10.3390/cancers15041246. Cancers (Basel). 2023. PMID: 36831588 Free PMC article.

9

Oligometastatic cancer in elderly patients: the "blitzkrieg" radiotherapy approach : SBRT in oligometastatic elderly patients.

Lancia A, Ingrosso G, Carosi A, Bottero M, Cancelli A, Turturici I, Ponti E, Santoni R. Lancia A, et al. Among authors: bottero m. Aging Clin Exp Res. 2019 Jan;31(1):109-114. doi: 10.1007/s40520-018-0937-6. Epub 2018 Mar 29. Aging Clin Exp Res. 2019. PMID: 29594874

10

Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature.

Francolini G, Detti B, Ingrosso G, Desideri I, Becherini C, Carta G, Pezzulla D, Caramia G, Dominici L, Maragna V, Teriaca MA, Bottero M, Livi L. Francolini G, et al. Among authors: bottero m. Crit Rev Oncol Hematol. 2018 Nov;131:24-29. doi: 10.1016/j.critrevonc.2018.08.010. Epub 2018 Aug 28. Crit Rev Oncol Hematol. 2018. PMID: 30293702 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page